𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome

✍ Scribed by Takeshi Iwatsubo; David M. A. Mann; Asano Odaka; Nobuhiro Suzuki; Dr Yasuo Ihara


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
701 KB
Volume
37
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The chronological relationship regarding deposition of amyloid β protein (Aβ) species, Aβ40 and Aβ42(43), was investigated in 16 brains from Down syndrome patients aged 31 to 64 years. The frontal cortex was probed with two end‐specific monoclonals that recognize Aβ40 or Aβ42(43). All senile plaques detected with an authentic β monoclonal were also Aβ42(43) positive, but only a varying proportion was Aβ40 positive. In young (≤ 50 years old) brains there were many Aβ42(43)‐positive, Aβ40‐negative diffuse plaques, but only few Aβ40‐positive senile plaques (mean, 6.3% of total number of senile plaques). The 2 youngest Down syndrome brains showed only diffuse plaques that were all Aβ42(43) positive but Aβ40 negative. Old (≤ 50 years old) brains contained many mature senile plaques with amyloid cores in addition to diffuse and immature plaques and the proportion of Aβ40‐positive senile plaques was increased (mean, 42% of total). Cerebral amyloid angiopathy was more abundant in old Down syndrome brains and was positive for both Aβ40 and Aβ42(43). In cerebral amyloid angiopathy, Aβ40 predominated over Aβ42(43) in both staining intensity and number of positive vessels. These results indicate that (1) the Aβ species intially deposited in the brain as senile plaques is Aβ42(43) and Aβ40 only appears a decade later, and (2) in cerebral amyloid angiopathy Aβ40 appears as early as Aβ42(43).


📜 SIMILAR VOLUMES


Amyloid β protein (Aβ) deposition in chr
✍ Dr. D. M. A. Mann; T. Iwatsubo; N. J. Cairns; P. L. Lantos; D. Nochlin; S. M. Su 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 893 KB

Amyloid f3 protein (AD) deposition was investigated in the frontal cortex of 8 cases of (genetically confirmed) chromosome 14-linked Alzheimer's disease (AD) using the end-specific monoclonal antibodies BA27 and BC05 to detect the presence of AP4,, and AfL,2(431, respectively. In all patients, AP42(

Relative efficacies of amyloid β peptide
✍ Scott Webster; Joseph Rogers 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 881 KB

The aggregation of amyloid P peptide (AP) into its fibrillar, cross P-pleated configuration is generally viewed as a critical event in the pathophysiology of Alzheimer's disease (AD). A diverse group of molecules, the AP binding proteins, has been evaluated for their effects on this process. However

Occurrence of the diffuse amyloid β-prot
✍ Haruhiko Akiyama; Hiroshi Mori; Takaomi Saido; Hiromi Kondo; Kenji Ikeda; Patric 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 697 KB

Diffuse amyloid beta-protein (Abeta) deposits with numerous glial cells containing C-terminal Abeta fragments occur in the cerebral cortex of patients with Alzheimer's disease. By using a panel of antibodies specific for various epitopes in the Abeta peptide, we have investigated the immunohistochem